ResearcherUniversity of LeicesterActive in the last 2 years
John Isherwood
Matched on ORCID iD 0000-0002-1171-0193; OpenAlex author ID A5079164075. Sources: OpenAlex.
Their work
- Papers
- 9
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2014: 2 papers · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 9
- Impact of social deprivation upon the preoperative pathway and early surgical outcomes after pancreatoduodenectomy for PDAC and non-PDAC periampullary cancer i… Co-author DOI 10.1016/j.hpb.2025.07.007↗
- PET-CT in the staging of potentially resectable pancreatic cancer Co-author DOI 10.21203/rs.3.rs-3079385/v1↗
- Proteomic Characterization of Circulating Molecular Perturbations Associated With Pancreatic Adenocarcinoma Following Intravenous ω-3 Fatty Acid and Gemcitabin… Co-author DOI 10.1002/jpen.1952↗
- Myeloid derived suppressor cells are reduced and T regulatory cells stabilised in patients with advanced pancreatic cancer treated with gemcitabine and intrave… Co-author DOI 10.21037/atm.2020.02.02↗
- Endothelial Progenitor Cells are Increased in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine and Intravenous Omega 3 Compared with Controls Co-author DOI 10.21203/rs.3.rs-36878/v1↗
- Treatment Access and Survival Amongst British Asians with Pancreatic Cancer. Co-author DOI 10.1007/s00268-016-3707-7↗
- Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer. Co-author DOI 10.18632/oncotarget.20250↗
- Cellular and plasma uptake of parenteral omega-3 rich lipid emulsion fatty acids in patients with advanced pancreatic cancer. Co-author DOI 10.1016/j.clnu.2013.09.017↗
- Restoration of mannose-binding lectin complement activity is associated with improved outcome in patients with advanced pancreatic cancer treated with gemcitab… Co-author DOI 10.1177/0148607113476304↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ashley Robert Dennison · 8 shared papers, 2014–2023 · strength 0.80
- Paper PET-CT in the staging of potentially resectable pancreatic cancer DOI 10.21203/rs.3.rs-3079385/v1↗
- Paper Proteomic Characterization of Circulating Molecular Perturbations Associated With Pancreatic Adenocarcinoma Following I… DOI 10.1002/jpen.1952↗
- Paper Myeloid derived suppressor cells are reduced and T regulatory cells stabilised in patients with advanced pancreatic can… DOI 10.21037/atm.2020.02.02↗
- Ali Raza Arshad · 5 shared papers, 2014–2021 · strength 0.45
- Paper Proteomic Characterization of Circulating Molecular Perturbations Associated With Pancreatic Adenocarcinoma Following I… DOI 10.1002/jpen.1952↗
- Paper Myeloid derived suppressor cells are reduced and T regulatory cells stabilised in patients with advanced pancreatic can… DOI 10.21037/atm.2020.02.02↗
- Paper Endothelial Progenitor Cells are Increased in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine and Int… DOI 10.21203/rs.3.rs-36878/v1↗
- Franscois Runau · 3 shared papers, 2020–2021 · strength 0.35
- Paper Proteomic Characterization of Circulating Molecular Perturbations Associated With Pancreatic Adenocarcinoma Following I… DOI 10.1002/jpen.1952↗
- Paper Myeloid derived suppressor cells are reduced and T regulatory cells stabilised in patients with advanced pancreatic can… DOI 10.21037/atm.2020.02.02↗
- Paper Endothelial Progenitor Cells are Increased in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine and Int… DOI 10.21203/rs.3.rs-36878/v1↗
- Wen Yuan Chung · 4 shared papers, 2014–2020 · strength 0.30
- Paper Myeloid derived suppressor cells are reduced and T regulatory cells stabilised in patients with advanced pancreatic can… DOI 10.21037/atm.2020.02.02↗
- Paper Endothelial Progenitor Cells are Increased in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine and Int… DOI 10.21203/rs.3.rs-36878/v1↗
- Paper Restoration of mannose-binding lectin complement activity is associated with improved outcome in patients with advanced… DOI 10.1177/0148607113476304↗
- Giuseppe Garcea · 2 shared papers, 2017–2023 · strength 0.29
- Neil Bhardwaj · 1 shared paper, 2023 · strength 0.20
- Tareq Alsaoudi · 1 shared paper, 2023 · strength 0.20
- Donald J. L. Jones · 1 shared paper, 2021 · strength 0.15
- Margaret M. Manson · 1 shared paper, 2017 · strength 0.06
- Patricia Adamo · 1 shared paper, 2017 · strength 0.06
- Jacqui Shaw · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.